Search Results 501-510 of 17696 for SC

  1. A Study To Evaluate The Safety And Efficacy Of ABT-494 For Induction And Maintenance Therapy In Subjects With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    ... [SC] or intramuscular ... at least one 2-week induction regimen of golimumab (one 200 mg SC dose followed by one 100 mg SC dose at least 2 weeks apart); ...

  2. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  3. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  4. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  5. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  6. Publications - Bradley Bragg, M.D. - Mayo Clinic

    Sheele JM, Bragg KJ, Bragg B, Campos SC, Elkins JM, Niforatos JD, Thompson CL. Descriptive epidemiology of women in the emergency department with gonorrhea ...

  7. Julia Fulmer's story: Beating cancer like a rock star - Mayo Clinic News Network

    Cancer is something no teenager should ever have to go through, but a teen from South Carolina proves that with a smile on her face she could overcome ...

  8. Publications - Kah Whye Peng, Ph.D. - Mayo Clinic

    ... SC, Rafael G, Tran S, Baum A, Kyratsous CA, Peng KW, Russell SJ. IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for ...

  9. Study Of XmAb®819 In Subjects With Advanced Clear Cell Renal Cell Carcinoma - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed ...

  10. Pasireotide (subcutaneous route, intramuscular route) - Side effects & dosage - Mayo Clinic

    Pasireotide injection is also used for the treatment of acromegaly (a growth hormone disorder) in patients who cannot be treated with surgery. Signifor® is ...